Smith Stan bought MAIA
October 1, 2025 · Form 4 insider transaction
Smith Stan bought 19,230 shares of MAIA Biotechnology, Inc. at $1.30 per share, a transaction worth $25.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
19,230
Price
$1.30
Total value
$25.0K
InsiderSmith Stan
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateOctober 1, 2025
Filing dateOctober 2, 2025
Shares owned after1,324,289
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on October 1, 2025; These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.